Literature DB >> 16274971

Computational approaches to modeling drug transporters.

Cheng Chang1, Peter W Swaan.   

Abstract

Computational modeling has advanced our understanding of drug absorption, tissue distribution, excretion and toxicity profiles by providing both direct and indirect knowledge of drug-transporter interactions that would otherwise be unavailable using experimental methods. Currently, two complementary approaches are available in modeling transporters: substrate-based and transporter-based methods. The transporter-based approach directly predicts the transporter's three-dimensional structure to assist in understanding the drug transport process, whereas substrate-based models infer such information by studying a group of substrates or inhibitors with measured activities. In this review, the available strategies in both transporter-based and substrate-based approaches are explained and illustrated with applications and case studies. With increasing computational power and continuously improving modeling algorithms, computational techniques can assist in further understanding transporter-substrate interactions as well as, the optimization of transporter-directed drug design.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274971     DOI: 10.1016/j.ejps.2005.09.013

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

Review 2.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

3.  Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.

Authors:  Denzil Bernard; Andrew Coop; Alexander D MacKerell
Journal:  J Med Chem       Date:  2007-03-17       Impact factor: 7.446

Review 4.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

Review 5.  Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.

Authors:  Chayan Acharya; Andrew Coop; James E Polli; Alexander D Mackerell
Journal:  Curr Comput Aided Drug Des       Date:  2011-03       Impact factor: 1.606

Review 6.  Determination and modelling of stereoselective interactions of ligands with drug transporters: a key dimension in the understanding of drug disposition.

Authors:  P Bhatia; M Kolinski; R Moaddel; K Jozwiak; I W Wainer
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

7.  Crucial role for phylogenetically conserved cytoplasmic loop 3 in ABCC4 protein expression.

Authors:  Satish B Cheepala; Ju Bao; Deepa Nachagari; Daxi Sun; Yao Wang; Tao P Zhong; Tao Zhong; Anjaparavanda P Naren; Jie Zheng; John D Schuetz
Journal:  J Biol Chem       Date:  2013-06-13       Impact factor: 5.157

8.  Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions.

Authors:  Alexander Sedykh; Denis Fourches; Jianmin Duan; Oliver Hucke; Michel Garneau; Hao Zhu; Pierre Bonneau; Alexander Tropsha
Journal:  Pharm Res       Date:  2012-12-27       Impact factor: 4.200

Review 9.  Molecular modeling and ligand docking for solute carrier (SLC) transporters.

Authors:  Avner Schlessinger; Natalia Khuri; Kathleen M Giacomini; Andrej Sali
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

10.  Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.

Authors:  Siennah R Miller; Thomas R Lane; Kimberley M Zorn; Sean Ekins; Stephen H Wright; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2021-05-12       Impact factor: 3.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.